Skip to main content
NCBI home page
Heliyon logoLink to Heliyon
. 2021 May 12;7(5):e07021. doi: 10.1016/j.heliyon.2021.e07021

Effect of naturally isolated hydroquinone in disturbing the cell membrane integrity of Pseudomonas aeruginosa MTCC 741 and Staphylococcus aureus MTCC 740

Venkadapathi Jeyanthi a,b,∗, Palaniyandi Velusamy a,∗∗, Govindarajan Venkat Kumar a,c, Kannan Kiruba d
PMCID: PMC8134992  PMID: 34036196

Abstract

Nosocomial pathogens cause various health problems in human and many novel drugs are under investigation to combat the pathogens. The present study explains the naturally derived hydroquinone possible mode of action against Pseudomonas aeruginosa MTCC 741 and Staphylococcus aureus MTCC 740. Time kill studies, cell viability assays, membrane potential assays, and potassium release assays were carried out to study the mode of action. Time kill studies revealed the rapid death of bacterial pathogens exposed to 4X MIC (Minimum inhibitory concentration) of the hydroquinone. Cell viability assay results showed that nearly half of the cell destruction of test pathogens occurred within one hour. Transmission electron microscopic (TEM) observations revealed the disruption of the cell membrane, which caused severe ultrastructural changes in both test pathogens. Hydroquinone dissipated the membrane potential of test pathogens, as confirmed by the depolarization of membrane potential, increases in permeability and leakage of intracellular potassium ions. At the concentration of 2X MIC hydroquinone in 5 min, about 91.41% and 84.85% potassium ions were released from P. aeruginosa MTCC 741 and S. aureus MTCC 740, respectively. This is the first report on the mode of action of naturally derived hydroquinone against clinical pathogens.

Keywords: Hydroquinone, Pseudomonas aeruginosa MTCC 741, Staphylococcus aureus MTCC 740, Cell viability, Membrane damage

Hydroquinone; Pseudomonas aeruginosa MTCC 741; Staphylococcus aureus MTCC 740; Cell viability; Membrane damage

1. Introduction

In recent years, a rapid increase in serious infections caused by clinical pathogens that are resistant to multiple antibiotics has been observed. Among various pathogens, infections caused by Pseudomonas aeruginosa and Staphylococcus aureus are amongst the most serious threats to human health (Gerits et al., 2016). The opportunistic pathogen Pseudomonas aeruginosa is a Gram-negative, rod-shaped bacterium and responsible for 10–15% of nosocomial infections worldwide (Strateva et al., 2007). It is the common cause of hospital-acquired, healthcare-associated, and ventilator-associated pneumonia. It is a major threat to public health because of its ubiquitous nature (Ullah et al., 2016). Furthermore, it represents a significant cause of morbidity in patients suffering from serious burns, cystic fibrosis, urinary tract infections, sepsis, and receiving intensive care treatment (Youssef et al., 2011; Ouberai et al., 2011). The Gram-positive, cocci shaped Staphylococcus aureus is another important pathogen that is generally involved in nosocomial and community-acquired infections. The nosocomial-acquired infections include bacteremia, surgical wound infections, and implant-related infections. Infections caused by community- acquired S. aureus involve skin, soft tissue infections and pneumonia (Moellering, 2006; Gerits et al., 2016). Over the years, S. aureus has developed multiple strategies to suppress the human immune system and withstand antibiotic therapy. This led to the emergence and spread of methicillin-resistant Staphylococcus aureus (MRSA), which has caused a major problem to human society (Tong et al., 2015). P. aeruginosa and S. aureus are the most commonly found pathogens in the mucus of cystic fibrosis (CF) patients and both are associated with poor respiratory functions (Limoli and Hoffman, 2019; Orazi et al., 2019). Moreover, the emergence of antibiotic-resistant pathogens highlights the need for novel antimicrobial agents.

Quinones consist of an aromatic ring with two substitutions for ketones. The antimicrobial activity of quinones is derived from their ability to donate free radicals. Reactive oxygen species (ROS) are a group of free radicals having a significant antimicrobial effect against bacterial pathogens (Memar et al., 2018). The aromatic organic compound hydroquinone has been used for decades in the treatment of hyperpigmentation disorders (Parsaeimehr et al., 2017). It is also known as benzene-1, 4-diol and, most commonly used chemical agent for skin lightning. It is widely used for the production of antioxidants, agrochemicals, polymers, cosmetics, pharmaceuticals as well as in paper manufacturing and photographic developers (Ghadimi et al., 2017). Apart from this, it is also shown to have different biological activities such as antibacterial, insecticidal, cytotoxicity, phospholipase A2 (PLA2) inhibitor and anti-HIV properties (Qiu and Wang, 2008). Generally, hydroquinone is chemically synthesized using benzene as the starting material. In general, humans are exposed to hydroquinone by occupational, food and environmental sources and are associated with an increased risk of adverse health effects (DeCaprio, 1999). The benzene derivative compound named hydroquinone (benzene-1, 4-diol) has the molecular formula is C6H6O2. It is soluble in water and has a molecular weight of 110.112 Da. In our previous study, we isolated a naturally derived hydroquinone from halotolerant Bacillus methylotrophicus MHC10 inhabiting a saltpan to counteract those drawbacks (Jeyanthi et al., 2016). It has been suggested that flow cytometry is a quick and reliable method to study the effect of antimicrobial agents on bacterial cells. It is a popular technique for the analysis of individual cells and yields information within minutes. To determine the cell viability, fluorescent nucleic acid binding dye, propidium iodide (PI) is widely used. PI can only penetrate cells with compromised bacterial membranes, binding to the nucleic acid of dead or damaged cells by intercalating between the bases (Novo et al., 2000). Meanwhile, the flow cytometric analysis of bacterial membrane potential was carried out for many years using membrane potential-sensitive fluorescent probe, DiSC3(5) (Zhang et al., 2000). Membrane potential (MP) is of crucial importance in bacterial physiology. It enables various processes such as ATP production, bacterial autolysis, transport of glucose, chemotaxis, and survival at low pH (Novo et al., 1999). For many antimicrobial agents, bactericidal activity through the disruption of membrane potential is the proposed mechanism of action (Silverman et al., 2003). Hence, the present study was undertaken to determine the possible mode of action of hydroquinone on the membrane of S. aureus and P. aeruginosa as test pathogens.

2. Materials and methods

2.1. Naturally derived hydroquinone and test pathogens

The production, purification, and characterization of antimicrobial compound hydroquinone from halotolerant Bacillus methylotrophicus MCC 2831 were previously reported by our research team (Jeyanthi et al., 2016). The MIC values of purified hydroquinone were found to be 7.81 μg/mL and 15.625 μg/mL against P. aeruginosa MTCC 741 and S. aureus MTCC 740 respectively. The same test pathogens were used for this study and the culture were maintained in Trypticase Soy Broth (TSB) medium (Hi-Media Laboratories, Mumbai, India) containing 20 % (v/v) glycerol at -70 °C.

2.2. Time-kill kinetics assay

Time-kill kinetic studies of hydroquinone treated bacterial pathogens was performed according to the National Committee for Clinical Laboratory Standard (NCCLS) guidelines (NCCLS, 2006). The bacterial culture was diluted in Mueller Hinton Broth (MHB) medium to adjust the cell density to approximately 107 CFU/mL. The death rate was evaluated by measuring the reduction in viable bacteria (log 10 CFU/mL) at 2 h time intervals for 24 h at 4X MIC of the compound. Samples were removed at defined intervals and the serially diluted samples were plated on (Mueller Hinton agar) MHA medium for the enumeration of colonies. The time-kill curves for bacterial pathogens were constructed by plotting numbers of viable cells versus time. The maximum killing was observed in the concentration of 4X MIC of the compound. All the experiments were performed in triplicates. The statistical analysis was performed using ORIGIN PRO software.

2.3. Determination of cell viability

The cell viability of P. aeruginosa MTCC 741 and S. aureus MTCC 740 treated with hydroquinone was determined using a BD FACS calibur flow cytometry system (BD Biosciences, USA) (Novo et al., 2000). The suspension (107 CFU/mL) of test bacterial pathogens was treated with 4X MIC of hydroquinone for 1 h and 2 h. The untreated bacteria were used as negative control. The bacterial cells were then harvested, washed twice with phosphate-buffered saline (PBS) and, resuspended in the same buffer. To the cell suspension, PI dye (final concentration 2 μg/mL) was added. It was then incubated for 15 min at room temperature to enable the uptake of dye. The dead bacteria are stained fluorescent red by PI. The PI fluorescence was excited at 485 nm and was measured at 620 nm using a BD FACSCalibur flow cytometry system (BD Biosciences, USA). For analyzing the data, BD CellQuest Pro software was used. Based on the side light scatter and PI, the R2 and R3 gates were used to identify live and damaged or dead cells, respectively. All the experiments were performed in triplicates.

2.4. Electron microscopic analysis

The electron microscopic analysis of hydroquinone treated bacterial pathogens was examined according to the method of Hartmann et al. (2010). TEM was used to examine the ultrastructural changes in test pathogens. The bacterial suspension (107 CFU/mL) was treated with 4X MIC of the compound for 30 min, 1 h and 2 h against P. aeruginosa MTCC 741 and S. aureus MTCC 740, individually. A drop of treated bacterial suspension was placed onto the TEM grid. It was then fixed with 2 % glutaraldehyde for 1 h and washed thrice with distilled water. Then, it was post fixed with 0.2% osmium tetroxide for 1 h followed by the dehydration of samples with ethanol series (30, 50, 70, 85 and 100 %) and air-dried. Finally, ultrastructural changes in the bacterial cells were examined by using FEI-Philips TECHNAI 10 TEM (FEI Company, USA) under standard operating conditions.

2.5. Membrane potential assay

The membrane potential of S. aureus MTCC 740 and P. aeruginosa MTCC 741 was tested using the fluorescence probe DiSC3(5) by the method of Huang and Yousef (2014). Bacterial cells in the mid-logarithmic phase were centrifuged, washed in 5mM HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, pH 7.8) and resuspended in the same buffer to an optical density at 600nm of 0.05. The fluorescent probe DiSC3(5) was added to the cell suspension to a final concentration of 0.5 μM. The mixture was incubated for 15 min at room temperature to allow the uptake of the DiSC3(5) probe. After incubation, potassium chloride was added to the cell suspension at a final concentration of 100mM. To the 900μL of cell suspension, 100 μL of 4X MIC Hydroquinone was added and incubated for 30 min and 1h separately. For the negative control, the live (untreated) bacteria were used. The proton ionophore, CCCP (10μM) treated with the bacterial pathogen for 1h was used as the positive control. A change in fluorescence due to membrane depolarization was recorded using a BD FACSCalibur flow cytometry system at an excitation wavelength of 622 nm and an emission wavelength of 670 nm. All the experiments were performed in triplicates.

2.6. Potassium release assay

Potassium ions released from P. aeruginosa MTCC 741 and S. aureus MTCC 740 cells were determined followed by the method of Huang and Yousef (2014) using a K+-sensitive probe, PBFI which is impermeable to bacterial cells. Bacterial cells in the mid-logarithmic phase were centrifuged, washed in 5 mM HEPES buffer, and resuspended in the same buffer to an optical density at 600 nm of 0.05. To 900 μL of the cell suspension, 10 μL of the 1mM PBFI probe was added. This was followed by the addition of 100 μL of 1X and 2X MIC of hydroquinone. A change in fluorescence corresponding to potassium concentration for every 1 min over 5 min was recorded using the BD FACSCalibur flow cytometer at an excitation wavelength of 346 nm and an emission wavelength of 505 nm. All the experiments were performed in triplicates. The statistical analysis was performed using ORIGIN PRO software.

3. Results and discussion

3.1. Time-kill kinetics studies

The killing kinetics were analyzed to evaluate the activity of hydroquinone against test pathogens. It can determine the bactericidal or bacteriostatic activity of an agent over time. Both test pathogens, P. aeruginosa MTCC 741, and S. aureus MTCC 740 showed an effective response to 4X MIC of hydroquinone treatment. In P. aeruginosa MTCC 741, there was a 3-log reduction in the number of CFU/mL in 2 h and further 3-log reduction was observed in 4 h (Figure 1A). In S. aureus MTCC 740, 1-log reduction was observed in 2 h, and a further 3-log reduction was noticed in 4 h (Figure 1B). The error bars in graph represented the standard error obtained from triplicate samples and P values included. Similar results were obtained with all three replicates. Many researchers have investigated the effect of quinone derivative compounds against clinical pathogens. Ooi et al. (2013) evaluated the time-kill kinetics of tert-butylhydroquinone (TBHQ) and tert-butylbenzoquinone (TBBQ) against Staphylococcus aureus SH1000. For the first 120 min of analysis, TBHQ had no effect on bacterial viability. The conversion of TBHQ to TBBQ initiated the bactericidal effect and showed a 5 log reduction in cell number within 3 h. Kim et al. (2010) reported the bactericidal effect of 2, 6-dimethoxy-1, 4-benzoquinone (DMBQ) by a time-kill curve experiment. The bactericidal effect of DMBQ was observed against S. typhimurium and S. aureus after 12 h of incubation. It indicated that doubling the MIC of DMBQ showed a significant reduction in the growth rate of bacterial pathogens.

Figure 1.

Figure 1

Open in a new tab

Time kill curves with (A) Pseudomonas aeruginosa MTCC 741 and (B) Staphylococcus aureus MTCC 740. Symbols: • growth control; ▪ hydroquinone 4X MIC. The results are given as the mean ± SD (n = 3) and ∗p-values of ≤0.05 are considered to be significant.

3.2. Determination of cell viability and biocompatibility

Many researchers have used the flow cytometry technique to determine the effect of antibacterial compounds on pathogens using fluorescent probes (Ruger et al., 2012). Novo et al. (2000) studied the cell viability of S. aureus and Micrococcus luteus treated with standard antibiotics such as amoxicillin, tetracycline, and erythromycin. Here the fluorescent probe PI, bound to the nucleic acid of dead and damaged cells with compromised bacterial membranes after 4 h of exposure to antibiotics. Similarly, in our previous study (Jeyanthi and Velusamy 2016), the cell viability of MRSA treated with 4X MIC of the phenolic compound for different time intervals was investigated. The nucleic acid probe, PI bound to DNA by intercalating between the bases and emitted red fluorescence. In our current study, the cell viability test was performed using flow cytometry to determine the antibacterial effect of 4X MIC of hydroquinone (Figure 2). Flow cytometry observation showed that the bacterial cell membrane was disrupted as the nucleic acid dye PI binds with bacterial nucleic acid. Therefore, the PI dye exhibited red fluorescence in the dead cells and the live cells emitted green fluorescence. It was observed that, within 1 h, nearly half the cell population was destroyed as 46.12 % and 50.52 % in P. aeruginosa MTCC 741 and S. aureus MTCC 740 respectively. Hydroquinone at 2–4% concentration is widely used for hyperpigmentation. No toxicity has been observed in human volunteers with the topical application (Talakoub et al., 2009; Stephens et al., 2018). However, its prolonged exposure at very high doses leads to skin disorders. Hence, the US Food and Drug Administration approved this compound as the triple-combination cream (TCC) containing 4% hydroquinone, 0.05% tretinoin and 0.01% fluocinolone acetonide for the topical treatment (Shin and Park, 2014). On the other hand, S. aureus and P. aeruginosa were the most common bacteria isolated from the skin lesions of patients with dermatitis. Hence, hydroquinone could act as a potent agent for treatment of skin disorders as well as an antibacterial agent. Shimada et al. (2012) studied the in vivo hydroquinone toxicity in mice by inhalation. Their findings showed that high dose exposure causes hepatic and renal adenoma. Likewise, in vitro hydroquinone toxicity studies on cultured human cell lines have been shown to cause mononuclear cell leukemia [Regev et al., 2012]. Similarly, tert-butylhydroquinone (tBHQ), a hydroquinone derivative is widely used as a food preservative. The acceptable daily intake of tBHQ is 0.7 mg/kg body weight as approved by the Joint FAO/WHO Expert Committee on Food Additives (JECFA). Some in vitro studies indicated that exposure to high levels of tBHQ was carcinogenic in animals (Gharavi et al., 2007). Hence, hydroquinone at higher concentration is a potential toxic agent to mammalian and human cells.

Figure 2.

Figure 2

Open in a new tab

Flow cytometric analysis represents the dot plot profiles of bacterial cells treated with 4X MIC of hydroquinone. The percentages of live (green fluorescence) and dead cells (red fluorescence) are mentioned.

3.3. Ultrastructural changes in test pathogens

The bacterial cell membrane is responsible for essential cellular functions. The membrane integrity is important for all functions and its disruption causes metabolic dysfunction, which leads to cell death (Lunde et al., 2009). In TEM analysis (Figure 3), the ultrastructural changes in bacteria were observed after treatment with 4X MIC of hydroquinone. The bacterial membrane damage of both P. aeruginosa MTCC 741 and S. aureus MTCC 740 was observed at 30 min and the membranes were deformed severely in 1 h. After 2 h, P. aeruginosa MTCC 741 cells appeared to be broken and in the case of S. aureus MTCC 740, the cell contents were expelled into the extracellular space. Hartmann et al. (2010) described the TEM analysis of bacterial cell damage in E. coli DSM 1103 and S. aureus DSM 1104 caused by antimicrobial peptides gramicidin S and peptidyl-glycylleucine-carboxyamide (PGLa). It revealed several distinct signs of damage to the cell envelope such as blisters, protruding bubbles on the cell surface of E. coli, and non-membrane-enclosed bodies were observed in S. aureus. Ultrastructural changes in P. aeruginosa and S. aureus treated with Burow's solution were studied by Hyo et al. (2012). Burow's solution is an aqueous solution of aluminium triacetate. It has antibacterial properties and is used as a topical treatment for skin infections. In both bacteria, they found that the cytoplasmic membrane was detached from the cell and the cytoplasmic contents were released out of the cell. The Gram-positive S. aureus is primarily composed of peptidoglycan. The hydroquinone treatment caused the accumulation of ROS and affects the peptidoglycan. Lipopolysaccharide is an essential component found on the outer membrane of Gram-negative P. aeruginosa. Many pieces of evidence showed that antimicrobial compounds could inhibit the lipid synthesis and blocked the movement of solutes between the periplasm and external cell surface (Epand et al., 2016). Porins are proteins found in the outer membrane of Gram-negative bacteria. They form water-filled open channels across the membrane that allows the transportation of ions, sugars and amino acids. Previous studies reported that antimicrobial compounds could pass through porins and creat pores in the cell membrane resulting in cellular damage (Pages and James, 2008). In the present study, TEM studies revealed that the hydroquinone treatment damaged the outer membrane of P. aeruginosa and S. aureus by ROS accumulation, through the creation of pores and resulting in bacterial death.

Figure 3.

Figure 3

Open in a new tab

TEM images of P. aeruginosa MTCC 741 and S. aureus MTCC 740 treated with 4X MIC hydroquinone. Untreated control cells (A, E). Cells treated for 30 min (B, F), 1h (C, G), 2h (D, H). The width of the images corresponds to a distance of 0.5 μm (A, B, E, F) and 0.2 μm (C, D G, H).

3.4. Effect of hydroquinone on cell membrane potential

Bacteria maintain a proton gradient known as the proton motive force (PMF), generated across the cell membrane. The PMF is necessary for ATP synthesis and to transport nutrients into the cells (Farha et al., 2013). The structure of the bacterial cell membrane can be disrupted by hydroquinone that causing membrane components and ions to be released into the bacterial broth. Many researchers also proved that aromatic compounds could interfere with the bacterial cell wall to make modifications in the integrity of the cytoplasmic membrane. This leads to the dissipation of proton-motive force (PMF) and prohibits the activity of membrane enzymes (Pumbwe et al., 2007). Herein, the aromatic derivative compound hydroquinone could have targeted the cytoplasmic membrane components on both Gram-negative as well as Gram-positive bacteria. The PMF consists of the sum of the electric potential (ΔΨ) and the transmembrane proton gradient (ΔpH). This gradient was assessed with a membrane potential-sensitive fluorescent probe, DiSC3 (5). This dye can penetrate the bacterial outer membrane, and is taken up by normal bacterial cells, depending on the magnitude of the cytoplasmic membrane's electrical potential gradient. It is then accumulated in the cytoplasmic membrane and causes self-quenching (Winkel et al., 2016). Herein, the effect of hydroquinone was studied on the membrane potential of P. aeruginosa MTCC 741 and S. aureus MTCC 740 (Figure 4). DiSC3 (5) probe accumulates in the healthier polarized cell membrane and the fluorescence decreases due to the partition of dye on the surface of polarized cells. Hence control cells (no drug treatment) produced a low signal. Hydroquinone at the concentration of 4X MIC significantly permeabilized the cell membrane of both bacterial species in 30 min. It led to the loss of membrane potential and the DiSC3 (5) was released into the medium leading to an increase in fluorescence. Within 1h, the membrane potential was further reduced and fluorescence intensity was increased. The positive control, carbonyl cyanide 3-chlorophenylhydrazone (CCCP), which is a membrane inhibitor, effectively permeabilized the membrane in 1h and produced more signal. Similarly, Zhang et al. (2000) indicated that the antibiotics such as Polymyxin B, Polymyxin E1, and Gramicidin S effectively permeabilized the cytoplasmic membrane of P. aeruginosa. The membrane was depolarized with the release of DiSC3 (5) and a consequent increase in fluorescence was observed. Huang and Yousef (2014) also demonstrated that DiSC3 (5) probe accumulated in the healthy polarized bacterial cell membrane and becomes self-quenched. The lipopeptide antibiotic paenibacterin at a concentration of 32 μg/mL significantly permeabilized the cell membrane of S. aureus. This lead to the membrane depolarization by releasing the DiSC3 (5) probe from the cell membrane, resulting in increased fluorescence.

Figure 4.

Figure 4

Open in a new tab

Changes in bacterial membrane potential of P. aeruginosa MTCC 741 and S. aureus MTCC 740 in the presence of 4X MIC hydroquinone.

3.5. Release of potassium ions (K+) by hydroquinone

Potassium is the most abundant intracellular cation present in bacteria and an essential part of the cellular process. The internal ionic environment of bacterial cells is generally rich in potassium ions. The leakage of this ion has been used to monitor the disruption of bacterial membrane caused by antibacterial agents (Orlov et al., 2002; Ochrombel et al., 2011). In the current study, membrane depolarization caused by hydroquinone led us to investigate whether membrane-associated functions affected or not. Treatment with hydroquinone triggered concentration-dependent leakage of the K+ from P. aeruginosa MTCC 741 and S. aureus MTCC 740. The leakage of potassium ions from P. aeruginosa MTCC 741 and S. aureus MTCC 740 bacterial cells were determined after treatment with 1X and 2X MIC of hydroquinone at every 1 min over 5 min. Hydroquinone treatment caused a concentration-dependent K+ leakage from bacterial cells. At low concentration (i.e., 1X MIC), the compound did not lead to significant potassium ion leakage from cells (Figure 5A). But at the concentration of 2X MIC in 5 min, about 91.41% and 84.85% potassium ions were released from P. aeruginosa MTCC 741 and S. aureus MTCC 740, respectively (Figure 5B). The error bars in graph represented the standard error obtained from triplicate samples and P values included. Similar results were obtained with all three replicates. Bonelli et al. (2006) performed the potassium release assay in M. flavus. They observed the most pronounced pore formation and rapid leakage of intracellular potassium ions induced by gallidermin and nisin at a concentration of 500 nM. In the present study, the action of the hydroquinone on test pathogens appeared to have similar effects. Higgins et al. (2005) also studied the potassium sensitive fluorescent probe PBFI to detect the leakage of K+ ions from MRSA exposed to a lipoglycopeptide antibiotic, telavancin. They found that the telavancin triggered the release of K+ ions from MRSA in a concentration-dependent manner, which confirmed the dissipation of cell membrane potential.

Figure 5.

Figure 5

Open in a new tab

Release of potassium ions from P. aeruginosa MTCC 741 (A) and S. aureus MTCC 740 (B) induced by 1X and 2X MIC of hydroquinone. The results are given as the mean ± SD (n = 3) and ∗p-values of ≤0.05 are considered to be significant.

4. Conclusion

From the present study, it was concluded that the hydroquinone is showing anti-bacterial efficacy against P. aeruginosa MTCC 741 and S. aureus MTCC 740. Hydroquinone caused bacterial cell death mainly by compromising cell membrane integrity. Time kill studies, cell viability assays, membrane potential assays, and potassium release studies revealed that the hydroquinone (different concentration at different time intervals) damage the cell membrane of the bacteria through oxidative stress caused by ROS and intracellular K+ ions was released from the bacteria cell membrane. Moreover, the cell membrane damage was visually confirmed through TEM analysis. TEM analysis revealed the destabilization of bacterial membrane and leakage of the cell contents. However, further molecular mechanism studies should be performed to better understand the effect of hydroquinone on bacterial outer membrane. Our study showed that naturally derived hydroquinone has strong antibacterial activity and it could be considered as a potent agent against bacterial pathogens. Further, studies of hydroquinone against other nosocomial pathogens are underway.

Declarations

Author contribution statement

Venkadapathi Jeyanthi: Conceived and designed the experiments; Performed the experiments; Wrote the paper.

Palaniyandi Velusamy: Conceived and designed the experiments; Contributed reagents, materials, analysis tools or data.

Govindarajan Venkat Kumar, Kannan Kiruba: Analyzed and interpreted the data; Wrote the paper.

Funding statement

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Data availability statement

Data included in article/supp. material/referenced in article.

Declaration of interests statement

The authors declare no conflict of interest.

Additional information

No additional information is available for this paper.

Acknowledgements

The authors wish to thank the management of SRM Institute of Science and Technology, Chennai for providing necessary facilities for undertaking this study. Additionally, the authors thank the University of Madras, Chennai for TEM analysis.

Contributor Information

Venkadapathi Jeyanthi, Email: jeyanthi.j1@gmail.com.

Palaniyandi Velusamy, Email: vels73@gmail.com.

References

  1. Bonelli R.R., Schneider T., Sahl H., Wiedemann I. Insights into in vivo activities of lantibiotics from Gallidermin and Epidermin mode-of-action studies. Antimicrob. Agents Chemother. 2006;50(4):1449–1457. doi: 10.1128/AAC.50.4.1449-1457.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. DeCaprio A.P. The toxicology of hydroquinone–relevance to occupational and environmental exposure. Crit. Rev. Toxicol. 1999;29(3):283–330. doi: 10.1080/10408449991349221. [DOI] [PubMed] [Google Scholar]
  3. Epand R.M., Walker C., Epand R.F., Magarvey N.A. Molecular mechanisms of membrane targeting antibiotics. Biochim. Biophys. Acta. 2016;1858(5):980–987. doi: 10.1016/j.bbamem.2015.10.018. [DOI] [PubMed] [Google Scholar]
  4. Farha M.A., Verschoor C.P., Bowdish D., Brown E.D. Collapsing the proton motive force to identify synergistic combinations against Staphylococcus aureus. Chem. Biol. 2013;20(9):1168–1178. doi: 10.1016/j.chembiol.2013.07.006. [DOI] [PubMed] [Google Scholar]
  5. Gerits E., Blommaert E., Lippell A., O’Neill A.J., Weytjens B., De Maeyer D. Elucidation of the mode of action of a new antibacterial compound active against Staphylococcus aureus and Pseudomonas aeruginosa. PloS One. 2016;11(5):e0155139. doi: 10.1371/journal.pone.0155139. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Ghadimi H., Ghani S.A., Amiri I.S. Elsevier Publisher; 2017. Electrochemistry of Dihydroxybenzene Compounds, Carbon Based Electrodes and Their Uses in Synthesis and Sensors; pp. 1–30. Chapter 1-Introduction. [Google Scholar]
  7. Gharavi N., Haggarty S., El-Kadi A.O.S. Chemoprotective and carcinogenic effects of tert-Butylhydroquinone and its metabolites. Curr. Drug Metabol. 2007;8(1):1–7. doi: 10.2174/138920007779315035. [DOI] [PubMed] [Google Scholar]
  8. Hartmann M., Berditsch M., Hawecker J., Ardakani M.F., Gerthsen D., Ulrich A.S. Damage of the bacterial cell envelope by antimicrobial peptides Gramicidin S and PGLa as revealed by transmission and scanning electron microscopy. Antimicrob. Agents Chemother. 2010;54(8):3132–3142. doi: 10.1128/AAC.00124-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Higgins D.L., Chang R., Debabov D.V., Leung J., Wu T., Krause K.M., Sandvik E., Hubbard J.M. Telavancin, a multifunctional lipoglycopeptide, disrupts both cell wall synthesisand cell membrane integrity in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 2005;49(3):1127–1134. doi: 10.1128/AAC.49.3.1127-1134.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Huang E., Yousef E.Y. The Lipopeptide antibiotic paenibacterin binds to the bacterial outer membrane and exerts bactericidal activity through cytoplasmic membrane damage. Appl. Environ. Microbiol. 2014;80(9):2700–2704. doi: 10.1128/AEM.03775-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hyo Y., Yamada S., Ishimatsu M., Fukutsuji K., Harada T. Antimicrobial effects of burow's solution on Staphylococcus aureus and Pseudomonas aeruginosa. Med. Mol. Morphol. 2012;45(2):66–71. doi: 10.1007/s00795-011-0540-9. [DOI] [PubMed] [Google Scholar]
  12. Jeyanthi V., Anbu P., Vairamani M., Velusamy P. Isolation of hydroquinone (benzene-1, 4-diol) metabolite from halotolerant Bacillus methylotrophicus MHC10 and its inhibitory activity towards bacterial pathogens. Bioprocess. Biosyst. Eng. 2016;39(3):429–439. doi: 10.1007/s00449-015-1526-0. [DOI] [PubMed] [Google Scholar]
  13. Jeyanthi V., Velusamy P. Anti-methicillin resistant Staphylococcus aureus compound isolation from halophilic Bacillus amyloliquefaciens MHB1 and determination of its mode of action using electron microscope and flow cytometry analysis. Indian J. Microbiol. 2016;56(2):148–157. doi: 10.1007/s12088-016-0566-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kim M.H., Jo S.H., Ha K.S., Song J.H., Jang H.D., Kwon Y.I. Antimicrobial activities of 1, 4-benzoquinones and wheat germ extract. J. Microbiol. Biotechnol. 2010;20(8):1204–1209. doi: 10.4014/jmb.1004.04037. [DOI] [PubMed] [Google Scholar]
  15. Limoli D.H., Hoffman L.R. Help, hinder, hide and harm: what can we learn from the interactions between Pseudomonas aeruginosa and Staphylococcus aureus during respiratory infections. Thorax. 2019;74(7):684–692. doi: 10.1136/thoraxjnl-2018-212616. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lunde C.S., Hartouni S.R., Janc J.W., Mammen M., Humphrey P.P., Benton B.M. Telavancin disrupts the functional integrity of the bacterial membrane through targeted interaction with the cell wall precursor lipid II. Antimicrob. Agents. Chemother. 2009;53(8):3375–3383. doi: 10.1128/AAC.01710-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Memar M.Y., Ghotaslou R., Samiei M., Adibkia K. Antimicrobial use of reactive oxygen therapy: current insights. Infect. Drug. Resist. 2018;11:567–576. doi: 10.2147/IDR.S142397. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Moellering R.C., Jr. The growing menace of community-acquired methicillin-resistant Staphylococcus aureus. Ann. Intern. Med. 2006;144(5):368–370. doi: 10.7326/0003-4819-144-5-200603070-00014. [DOI] [PubMed] [Google Scholar]
  19. NCCLS-National Committee for Clinical Laboratory Standards . NCCLS Document M7-A7. seventh ed. National Committee for Clinical Laboratory Standards; Wayne PA: 2006. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, Approved standard. [Google Scholar]
  20. Novo D.J., Perlmutter N.G., Hunt R.H., Shapiro H.M. Accurate flow cytometric membrane potential measurement in bacteria using diethyloxacarbocyanine and a ratiometric technique. Cytometry. 1999;35(1):55–63. doi: 10.1002/(sici)1097-0320(19990101)35:1<55::aid-cyto8>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  21. Novo D.J., Perlmutter N.G., Hunt R.H., Shapiro H.M. Multiparameter flow cytometric analysis of antibiotic effects on membrane potential, membrane permeability, and bacterial counts of Staphylococcus aureus and Micrococcus luteus. Antimicrob. Agents. Chemother. 2000;44(4):827–834. doi: 10.1128/aac.44.4.827-834.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Ochrombel I., Ott L., Kramer R., Burkovski A., Marin K. Impact of improved potassium accumulation on pH homeostasis, membrane potential adjustment and survival of Corynebacterium glutamicum. Biochim. Biophys. Acta. 2011;1807(4):444–450. doi: 10.1016/j.bbabio.2011.01.008. [DOI] [PubMed] [Google Scholar]
  23. Ooi N., Chopra I., Eady A., Cove J., Bojar R., O'Neill A.J. Antibacterial activity and mode of action of tert-butylhydroquinone (TBHQ) and its oxidation product, tert-butylbenzoquinone (TBBQ) J. Antimicrob. Chemother. 2013;68(6):1297–1304. doi: 10.1093/jac/dkt030. [DOI] [PubMed] [Google Scholar]
  24. Orazi G., Ruoff K.L., O'Toole G.A. Pseudomonas aeruginosa increases the sensitivity of biofilm-grown Staphylococcus aureus to membrane-targeting antiseptics and antibiotics. mBio. 2019;10(4):e01501–e01519. doi: 10.1128/mBio.01501-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Orlov D.S., Nguyen T., Lehrer R.I. Potassium release, a useful tool for studying antimicrobial peptides. J. Microbiol. Methods. 2002;49(3):325–328. doi: 10.1016/s0167-7012(01)00383-9. [DOI] [PubMed] [Google Scholar]
  26. Ouberai M., Garch F.E., Bussiere A., Riou M., Alsteens D., Lins L., Baussanne I., Dufrene Y.F., Brasseur R., Decout J.L., Mingeot-Leclercq M.P. The Pseudomonas aeruginosa Membranes: a target for a new amphiphilic aminoglycoside derivative. Biochim. Biophys. Acta. 2011;808(6):1716–1727. doi: 10.1016/j.bbamem.2011.01.014. Epub 2011 Feb 1. [DOI] [PubMed] [Google Scholar]
  27. Pages J.M., James C.E. Winterhalter M. The porin and the permeating antibiotic: a selective diffusion barrier in gram-negative bacteria. Nat. Rev. Microbiol. 2008;6(12):893–903. doi: 10.1038/nrmicro1994. [DOI] [PubMed] [Google Scholar]
  28. Parsaeimehr A., Martinez-Chapa S.O., Parra-Saldivar R. The Microbiology of Skin, Soft Tissue, Bone and Joint Infections. Volume 2 in Clinical Microbiology: Diagnosis, Treatments and Prophylaxis of Infections. 2017. Chapter 13-medicinal plants versus skin disorders: a survey from ancient to modern herbalism; pp. 205–221. [Google Scholar]
  29. Pumbwe L., Skilbeck C.A., Wexler H.M. Induction of multiple antibiotic resistance in Bacteroides fragilis by benzene and benzene-derived active compounds of commonly used analgesics, antiseptics and cleaning agents. J. Antimicrob. Chemother. 2007;60(6):1288–1297. doi: 10.1093/jac/dkm363. Epub 2007 Sep 20. [DOI] [PubMed] [Google Scholar]
  30. Qiu Y., Wang X.M. A new sesquiterpenoid hydroquinone from the marine sponge Dysidea arenaria. Molecules. 2008;13(6):1275–1281. doi: 10.3390/molecules13061275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Regev L., Wu M., Zlotolow R., Brautbar N. Hydroquinone, a benzene metabolite, and leukemia: a case report and review of the literature. Toxicol. Ind. Health. 2012;28(1):64–73. doi: 10.1177/0748233711404037. [DOI] [PubMed] [Google Scholar]
  32. Ruger M., Bensch G., Tungler R., Reichl U. A flow cytometric method for viability assessment of Staphylococcus aureus and Burkholderia cepacia in mixed culture. Cytometry. 2012;81(12):1055–1066. doi: 10.1002/cyto.a.22219. [DOI] [PubMed] [Google Scholar]
  33. Shimada A.L.B., Ribeiro A.L.T., Bolonheis S.M., Ferraz-de- Paula V., Hebeda C.B., Farsky S.H.P. In vivo hydroquinone exposure impairs MCP-1 secretion and monocyte recruitment into the inflamed lung. Toxicology. 2012;296(1–3):20–26. doi: 10.1016/j.tox.2012.02.012. [DOI] [PubMed] [Google Scholar]
  34. Shin J.W., Park K.C. Current clinical use of depigmenting agents. Dermatol. Sin. 2014;32(4):205–210. [Google Scholar]
  35. Silverman J.A., Perlmutter N.G., Shapiro H.M. Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus. Antimicrob. Agents Chemother. 2003;47(8):2538–2544. doi: 10.1128/AAC.47.8.2538-2544.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Stephens T.J., Babcock M., Bucay V., Gotz V. Split-face evaluation of a multi-ingredient brightening foam versus a reference control in women with photodamaged facial skin. J. Clin. Aesthet. Dermatol. 2018;11(10):24–28. [PMC free article] [PubMed] [Google Scholar]
  37. Strateva T., Raykova V.O., Markova B., Todorova A., Proevska Y.M., Mitov I. Problematic clinical isolates of Pseudomonas aeruginosa from the university hospitals in Sofia, Bulgaria: current status of antimicrobial resistance and prevailing resistance mechanisms. J. Med. Microbiol. 2007;56(7):956–963. doi: 10.1099/jmm.0.46986-0. [DOI] [PubMed] [Google Scholar]
  38. Talakoub L., Neuhaus I.M., Yu S.S. 2009. Chapter 2-Cosmeceuticals. Cosmetic Dermatology. The Requisites in Dermatology; pp. 7–34. [Google Scholar]
  39. Tong S.Y.C., Davis J.S., Eichenberger E., Holland T.L., Fowler V.G. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin. Microbiol. Rev. 2015;28(3):603–661. doi: 10.1128/CMR.00134-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Ullah W., Qasim M., Rahman H., Bari F., Khan S., Rehman Z.U., Khan Z., Dworeck T., Muhammad N. Multidrug resistant Pseudomonas aeruginosa: pathogen burden and associated antibiogram in a tertiary care hospital of Pakistan. Microb. Pathog. 2016;97:209–212. doi: 10.1016/j.micpath.2016.06.017. [DOI] [PubMed] [Google Scholar]
  41. Winkel J.D., Gray D.A., Seistrup K.H., Hamoen L.W., Strahl H. Analysis of antimicrobial-triggered membrane depolarization using voltage sensitive dyes. Front. Cell. Dev. Biol. 2016;4:29. doi: 10.3389/fcell.2016.00029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Youssef D., Bailey B., El-Abbassi A., Vannoy M., Manning T., Moorman J.P., Peiris A.N. Healthcare costs of methicillin resistant Staphylococcus aureus and Pseudomonas aeruginosa infections in Veterans: role of vitamin D deficiency. Eur. J. Clin. Microbiol. Infect. Dis. 2011;1(3):281–286. doi: 10.1007/s10096-011-1308-9. [DOI] [PubMed] [Google Scholar]
  43. Zhang L., Dhillon P., Yan H., Farmer S., Hancock R.E. Interactions of bacterial cationic peptide antibiotics with outer and cytoplasmic membranes of Pseudomonas aeruginosa. Antimicrob. Agents. Chemother. 2000;44(12):3317–3321. doi: 10.1128/aac.44.12.3317-3321.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

Data included in article/supp. material/referenced in article.

Articles from Heliyon are provided here courtesy of Elsevier

RESOURCES